Blog
Why Laboratory Leaders Are Re‑Thinking Their LIS Strategy in 2026 - and Where LigoLab Fits
January 9, 2026
Clinical and pathology laboratories are entering 2026 under a convergence of pressures that few anticipated a decade ago. Test volumes remain high, reimbursement rules continue to tighten, digital pathology is becoming operationally mainstream, and staffing shortages show little sign of easing. At the same time, regulators and payers are demanding greater transparency, traceability, and financial accuracy from laboratory operations.
These forces are driving a renewed evaluation of one foundational question: Is our laboratory information system helping us manage risk, or quietly amplifying it?
This is where platforms like LigoLab are increasingly part of the conversation.
Industry Insights: Best LIS Systems in 2026: Top Laboratory Information Systems Compared for Clinical, Pathology, and Outreach Labs
Industry Signals Driving LIS System Modernization
1. Reimbursement is Becoming Less Forgiving
Across the industry, labs are seeing expanded payer edits around medical necessity, diagnosis–procedure alignment, prior authorization, and eligibility verification. Post‑billing discovery of errors has become both costly and less recoverable.
What’s changing in buyer behavior: Laboratories are prioritizing LIS systems that surface laboratory billing and coverage issues before testing begins, not weeks later through denials.
Case Study: In-House vs. Outsourced Laboratory Billing – Navigating the Best Path Forward for Your Lab
2. Digital Pathology is Crossing the Operational Threshold
Whole‑slide imaging and remote sign‑out are no longer pilot projects for many pathology groups. As digital pathology adoption grows, informatics platforms must manage digital and physical workflows together, or risk fragmenting case context.
What’s changing in buyer behavior: Labs are looking beyond “digital compatibility” toward laboratory information system platforms that can natively support hybrid pathology models without parallel systems.
Case Study: OnePath - Transforming Pathology Lab Management Through Digital Innovation
3. Staffing Constraints Are Reshaping Workflow Design
Persistent shortages among technologists, histotechs, and laboratory billing specialists have shifted priorities. Manual checks, institutional memory, and heroics are no longer sustainable operating strategies.
What’s changing in buyer behavior: Automation, rule‑based workflows, and real‑time visibility are now core evaluation criteria, not optional enhancements.
Get Insight: How Laboratory Information Systems Help Lab Operators Overcome Industry-Wide Staffing Shortages
4. Compliance Expectations Continue to Rise
Accreditation bodies increasingly expect defensible audit trails, controlled access to PHI, and end‑to‑end traceability across specimens, instruments, and users. Informal logs and external spreadsheets are becoming visible liabilities.
What’s changing in buyer behavior: Labs are seeking LIS systems where compliance is embedded into everyday work rather than maintained as a parallel process.
Discover More: Reducing Risk in the Modern Laboratory - A Comprehensive Approach
How LigoLab Aligns With These Industry Realities
A Unified Clinical and Financial Data Model
One of LigoLab’s most differentiating characteristics is its native integration of laboratory operations and lab revenue cycle management (lab RCM). Clinical data, coding logic, payer rules, and laboratory billing workflows operate on a single foundation.
Why this resonates with prospects:
- Fewer missed or delayed charges
- Earlier identification of non‑billable orders
- Reduced denial rates
- Less manual reconciliation between laboratory software systems
As reimbursement pressure intensifies, this alignment directly addresses a growing source of financial risk.
Get Insight: The LigoLab Difference - Demonstrating the Power of Lab RCM Automation in the Clinical Laboratory
Workflow Intelligence That Reduces Human Dependency
LigoLab embeds configurable validation and routing rules at critical control points, including order entry, accessioning, testing, and sign-out.
Operational impact:
- Incomplete or incompatible orders are stopped early
- Reflex testing and add‑ons occur consistently
- Turnaround times become more predictable
For labs navigating staffing volatility, this reduces reliance on individual vigilance and institutional memory.
Discover More: Unleashing Laboratory Excellence - Here’s How LigoLab’s Automation Engine Supercharges Lab Performance
Audit Readiness as a Daily Byproduct
Every action taken on a case, viewing, editing, approving, or releasing, is automatically logged. Quality control activities, instrument records, and user access are tracked within the same system.
Strategic benefit: Audit preparation becomes incremental and continuous, rather than disruptive and episodic.
Discover More: A Detailed Look at How Modern Laboratory Information Systems Fully Support Quality Control
Scalability for Growth, Consolidation, and Specialization
Industry consolidation and service expansion remain active trends. Laboratory information systems that were sufficient for single‑site operations often struggle as complexity increases.
LigoLab’s configurable architecture allows laboratories to:
- Standardize workflows across locations
- Add new test types without re‑architecting systems
- Maintain operational visibility as volume grows
This scalability is increasingly relevant as labs plan beyond short‑term fixes.
Digital Pathology Without Data Fragmentation
As digital pathology adoption accelerates, maintaining case context becomes critical. LigoLab maintains images, annotations, and diagnostic data in connection with the same case record.
Why this matters: It reduces the risk of parallel workflows, orphaned digital assets, and context loss during review and sign‑out.
Industry Insights: ECPC’s Strategic Leap into Digital Pathology - A Connected Vision for the Future
Why This Message Resonates With Today’s Buyers
Prospective customers evaluating laboratory information system software platforms are increasingly focused on resilience rather than features. Common evaluation questions include:
- Will this LIS system mitigate operational and financial risk as volume grows?
- Can it support digital and hybrid diagnostic models without added complexity?
- Does it simplify compliance rather than add overhead?
- Will it consolidate our technology stack (instead of expanding it)?
LigoLab’s emphasis on integration, automation, and transparency aligns directly with these concerns.
White Paper: Vendor to Partner - How Aligning with Your LIS Provider Can Transform Your Lab
SEO‑Relevant Themes Driving Discovery
Search behavior among laboratory decision‑makers reflects these priorities. High‑intent themes include:
- Integrated LIS and revenue cycle management
- Laboratory workflow automation
- Digital pathology‑ready LIS software platforms
- Reducing lab billing denials in clinical laboratories
- Scalable LIS for pathology and reference labs
LigoLab naturally aligns with these terms because its platform addresses the same pressures labs are actively researching.
The Laboratory Information System as a Risk Management Strategy
The laboratory industry is no longer experiencing incremental change. Economic pressure, workforce constraints, and technological advancement are forcing a deeper reassessment of core systems.
In this environment, an LIS system is not merely an operational infrastructure; it is a core risk management strategy. By unifying clinical and financial workflows, embedding automation, and maintaining real‑time visibility, LigoLab positions laboratories to operate with confidence in an increasingly complex diagnostic landscape.
For prospects seeking stability, scalability, and long‑term readiness, that value proposition is becoming increasingly difficult to overlook.
Meet the Author
Suren Avunjian is the Co-Founder and Chief Executive Officer of LigoLab, where he leads company strategy, operations, and sustained growth across the clinical laboratory market. Under his leadership, LigoLab delivers enterprise-grade laboratory information system (LIS) and embedded laboratory revenue cycle management (lab RCM) software supporting anatomic pathology, clinical laboratory, molecular diagnostics, and direct-to-consumer lab testing, all on a single, highly configurable platform.
Avunjian is the driving force behind the LigoLab’s vision to modernize laboratory operations through automation, interoperability, and real-time visibility, paired with a deep commitment to customer service.
Widely respected for his industry insight, he is frequently featured in leading laboratory publications and forums.
